Indazoles

US8895544B2 · kind B2 · utility

Assignee

• PFIZER INC. · US

Inventors

• Jotham Wadsworth Coe · Niantic, US
• Christoph Martin Dehnhardt · New York, US
• Peter Jones · Sharon, US
• Steven Wade Korturn · Groton, US
• Yogesh Anil Sabnis · Sandwich, GB
• Florian Wakenhut · Sandwich, GB
• Gavin Alistair Whitlock · Sandwich, GB

Key dates

• Filing date: Sep 30, 2013
• Grant date: Nov 25, 2014
• Expiry date: Sep 30, 2033

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A method of treating a disease or condition for which a JAK inhibitor is indicated in a subject in need of such treatment, comprising administering to the subject a therapeutically effective amount of a compound of formula (I)or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate of said compound or pharmaceutically acceptable salt, and particularly, a method for the treatment of various inflammatory diseases, particularly psoriasis, asthma and COPD.